SAS has secured a potential $49.9M blanket purchase agreement to provide the Food and Drug Administration access to the company’s
The Food and Drug Administration is looking to deploy artificial intelligence-based capabilities to support the drug product assessments and business…
The Food and Drug Administration has awarded Booz Allen Hamilton (NYSE: BAH) and Octo Consulting Group spots on a potential
